IN2014MU00215A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MU00215A IN2014MU00215A IN215MU2014A IN2014MU00215A IN 2014MU00215 A IN2014MU00215 A IN 2014MU00215A IN 215MU2014 A IN215MU2014 A IN 215MU2014A IN 2014MU00215 A IN2014MU00215 A IN 2014MU00215A
- Authority
- IN
- India
- Prior art keywords
- mucoadhesive
- relates
- tablet
- mucoadhesive tablet
- pregabalin
- Prior art date
Links
- 230000003232 mucoadhesive effect Effects 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a mucoadhesive tablet comprising pregabalin with at least one mucoadhesive excipient, at least one swelling agent and at least one gelling agent, wherein the mucoadhesive tablet maintains gastric retention for the time period during which the drug is released into the stomach. Further it relates to a process for the preparation of the mucoadhesive tablet.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN215MU2014 IN2014MU00215A (en) | 2014-01-22 | 2015-01-20 | |
PCT/IN2015/000033 WO2015114656A2 (en) | 2014-01-22 | 2015-01-20 | Mucoadhesive tablet of pregabalin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN215MU2014 IN2014MU00215A (en) | 2014-01-22 | 2015-01-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MU00215A true IN2014MU00215A (en) | 2015-08-28 |
Family
ID=53757863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN215MU2014 IN2014MU00215A (en) | 2014-01-22 | 2015-01-20 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN2014MU00215A (en) |
WO (1) | WO2015114656A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6919119B2 (en) * | 2017-01-23 | 2021-08-18 | 日新製薬株式会社 | A compressed solid pharmaceutical composition containing a γ-aminobutyric acid derivative substituted at the 3-position. |
CN108159011A (en) * | 2018-03-16 | 2018-06-15 | 中国药科大学 | A kind of Pregabalin stomach retention sustained-release piece of biphasic controlled release and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012322323B2 (en) * | 2011-10-11 | 2016-04-21 | Sun Pharmaceutical Industries Limited | A gastroretentive dosage system and process of preparation thereof |
-
2015
- 2015-01-20 IN IN215MU2014 patent/IN2014MU00215A/en unknown
- 2015-01-20 WO PCT/IN2015/000033 patent/WO2015114656A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015114656A2 (en) | 2015-08-06 |
WO2015114656A3 (en) | 2015-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
PH12017501035A1 (en) | Method for the production of a pharmaceutical delivery system | |
PH12016501841A1 (en) | Immunosuppressant formulation | |
EP3102188A4 (en) | Novel disintegration systems for pharmaceutical dosage forms | |
IN2014MU00303A (en) | ||
MA39710A (en) | Topical composition for use in the treatment of inflammatory bowel disease | |
IN2014DN06966A (en) | ||
MX2022015606A (en) | Immediate-release tablets containing a drug and processes for forming the tablets. | |
MX2017001487A (en) | Sofosbuvir in crystalline form and process for its preparation. | |
MX2020009444A (en) | Low dose oral pharmaceutical composition of isotretinoin. | |
NZ725577A (en) | Modified release coated capsules | |
PH12016501059A1 (en) | A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation | |
MA40313A (en) | Oral pharmaceutical composition of isotretinoin | |
NZ725578A (en) | Modified release coated capsules | |
SG11201609948YA (en) | Lobaplatin crystal, preparation method and pharmaceutical application | |
PL3237375T3 (en) | Crystals of alanine n-acetic acid precursors, process to prepare them and their use | |
MX2017007245A (en) | Methods of treating fibrosis. | |
IN2014MU00215A (en) | ||
EA202090913A1 (en) | COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON | |
PH12016502272A1 (en) | Ceritinib formulation | |
SI3236952T1 (en) | Pharmaceutical tablet composition | |
MX2014005153A (en) | Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain. | |
IL250419A0 (en) | Use in single pill/tablet/capsule of minocycline, fluconazole and atorvastatin in the treatment of multiple sclerosis | |
IN2014MU00198A (en) | ||
MX2016006742A (en) | Pharmaceutical composition. |